Lite Strategy LITS
NASDAQ LITS
$1.06 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Total Liabilities (2011 - 2026)

Lite Strategy (LITS) posted Total Liabilities of $952000.0 for Q1 2026, down 12.42% on a QoQ basis from $1.1 million in Q4 2025, and down 23.1% year-over-year from $1.2 million in Q1 2025.

Analysis

Lite Strategy (LITS) Total Liabilities (2011 - 2026) Analysis & Trends

Lite Strategy has reported Total Liabilities for 16 years, with the latest figure at $952000.0 in Q1 2026.

  • On a quarterly basis, Total Liabilities fell 23.1% year-over-year to $952000.0 in Q1 2026; TTM through Mar 2026 was $952000.0, a 23.1% decrease from a year earlier, with the FY2025 full-year figure at $1.4 million, down 83.79% from the prior year.
  • Total Liabilities was $952000.0 for Q1 2026 at Lite Strategy, down from $1.1 million in the prior quarter.
  • The five-year high for Total Liabilities was $126.6 million in Q1 2022, with the low at $952000.0 in Q1 2026.
  • Average Total Liabilities over 5 years is $44.2 million, with a median of $19.0 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2025: Total Liabilities gained 0.64% in 2022, then sank 93.88% in 2025.
  • Over 5 years, Total Liabilities stood at $99.2 million in 2022, then tumbled by 80.8% to $19.0 million in 2023, then plunged by 87.99% to $2.3 million in 2024, then tumbled by 52.47% to $1.1 million in 2025, then fell by 12.42% to $952000.0 in 2026.
  • The last three Total Liabilities figures came in at $952000.0 (Q1 2026), $1.1 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 83.95 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 37.53 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 7.18 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 10.02 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.62 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 4.20 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 4.20 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 13.24 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 384.62 Mn
10 Lite Strategy 38.03 Mn 30.49 Mn - 952,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 952,000.00
Dec 31, 2025 1.09 Mn
Sep 30, 2025 1.07 Mn
Jun 30, 2025 1.35 Mn
Mar 31, 2025 1.24 Mn
Dec 31, 2024 2.29 Mn
Sep 30, 2024 2.87 Mn
Jun 30, 2024 8.36 Mn
Mar 31, 2024 20.23 Mn
Dec 31, 2023 19.05 Mn
Sep 30, 2023 19.89 Mn
Jun 30, 2023 96.19 Mn
Mar 31, 2023 99.83 Mn
Dec 31, 2022 99.23 Mn
Sep 30, 2022 126.28 Mn
Jun 30, 2022 125.43 Mn
Mar 31, 2022 126.62 Mn
Dec 31, 2021 136.13 Mn
Sep 30, 2021 142.05 Mn
Jun 30, 2021 124.63 Mn